Skip to content

Coronally advanced flap combined with Geistlich Mucograft for the treatment of recession type defects: a randomized controlled clinical trial.

Coronally advanced flap combined with Geistlich Mucograft for the treatment of recession type defects: a randomized controlled clinical trial. - A prospective study on the Geistlich Mucograft collagen matrix.

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON38205
Enrollment
40
Registered
2012-01-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

recessiedefecten van gebitselementen gingival recesssion receding gums

Interventions

None listed

Sponsors

Universitair Medisch Centrum Sint Radboud
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Patients have to present in good general health 2. Only non-smokers will be included 3. Good oral hygiene, i.e. full-mouth plaque score (FMPS)

Exclusion criteria

Exclusion criteria: 1. Patients not fulfilling the inclusion criteria 2. Patient with uncontrolled or poorly controlled diabetes, using anticoagulants, presenting unstable or life-threatening conditions, or requiring antibiotic prophylaxis wil be exluded

Design outcomes

Primary

MeasureTime frame
The primary outcome variable will be recession depth (RECd).

Secondary

MeasureTime frame
Secondary outcome variables will be percentage of defect coverage, recession width (RECw), clinical attachment level (CAL), probing pocket depth (PPD), and width of keratinized tissue (KTw).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)